GetTopicDetailResponse(id=2d38101548e4, topicName=驗(yàn)證性3期臨床試驗(yàn), introduction=驗(yàn)證性3期臨床試驗(yàn), content=null, image=null, comments=1, allHits=995, url=https://h5.medsci.cn/topic?id=101548, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=100300, tagList=[TagDto(tagId=100300, tagName=驗(yàn)證性3期臨床試驗(yàn))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1951221, encodeId=785719512210e, content=<a href='/topic/show?id=2d38101548e4' target=_blank style='color:#2F92EE;'>#驗(yàn)證性3期臨床試驗(yàn)#</a>, objectTitle=Keytruda針對經(jīng)典霍奇金淋巴瘤的驗(yàn)證性3期臨床試驗(yàn)達(dá)到了主要終點(diǎn), objectType=article, longId=189427, objectId=cb2d18942e7b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2d18942e7b, replyNumber=0, likeNumber=82, createdTime=2020-06-20, rootId=0, userName=nakerunner, userId=0cd7162, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2d18942e7b, moduleTitle=Keytruda針對經(jīng)典霍奇金淋巴瘤的驗(yàn)證性3期臨床試驗(yàn)達(dá)到了主要終點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cb2d18942e7b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
